Avantax Planning Partners’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,936
Closed -$4.31K 493
2024
Q2
$4.31K Hold
12,936
﹤0.01% 471
2024
Q1
$2.98K Sell
12,936
-100,000
-89% -$29.1K ﹤0.01% 465
2023
Q4
$36K Hold
112,936
﹤0.01% 370
2023
Q3
$30.5K Buy
112,936
+100,000
+773% +$36.4K ﹤0.01% 356
2023
Q2
$6.53K Hold
12,936
﹤0.01% 366
2023
Q1
$8.51K Hold
12,936
﹤0.01% 367
2022
Q4
$4.49K Hold
12,936
﹤0.01% 365
2022
Q3
$6K Hold
12,936
﹤0.01% 345
2022
Q2
$5K Hold
12,936
﹤0.01% 341
2022
Q1
$8K Hold
12,936
﹤0.01% 357
2021
Q4
$14K Sell
12,936
-146,587
-92% -$227K ﹤0.01% 352
2021
Q3
$295K Sell
159,523
-30,000
-16% -$67.4K 0.01% 255
2021
Q2
$601K Hold
189,523
0.03% 179
2021
Q1
$616K Sell
189,523
-12,435
-6% -$45K 0.03% 169
2020
Q4
$126K Buy
+201,958
New +$92.3K 0.01% 286
2019
Q4
Sell
-1,000
Closed -$8K 321
2019
Q3
$8K Hold
1,000
﹤0.01% 304
2019
Q2
$17K Hold
1,000
﹤0.01% 297
2019
Q1
$31K Hold
1,000
﹤0.01% 291
2018
Q4
$29K Buy
+1,000
New +$45.4K ﹤0.01% 268

Other funds holding ASXC

Avantax Planning Partners's ASXC Position: Q3 2024 in Review

Avantax Planning Partners sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 12,936 shares — an estimated $4.31K sold.

Avantax Planning Partners first reported a position in ASXC in Q4 2018 and held it in 19 quarters. The position peaked at $616K in Q1 2021. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Avantax Planning Partners reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Avantax Planning Partners sold 12,936 Asensus Surgical, Inc. shares in Q3 2024, an estimated $4.31K.
  • Avantax Planning Partners first reported a position in Asensus Surgical, Inc. in Q4 2018 and held it in 19 quarters.
  • Avantax Planning Partners's Asensus Surgical, Inc. position peaked at $616K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Avantax Planning Partners's 13F filing for Q3 2024, filed 14 Nov 2024.